-
PROVIDERS
Watch now
Are you getting the full picture? A webinar series on the power of comprehensive intelligent diagnostics
-
LIFE SCIENCES
ENROLL NOW
Tempus’ Patient-Derived Organoid ScreensEvaluate the efficacy of your preclinical compounds using fixed organoid panels designed for diverse therapeutic applications.Space is limited — enroll by June 30, 2025, to secure your spot.
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Original Webinar Date:
04/22/2025
Alterations Drive Decisions: Advancing Personalized Care with Comprehensive Genomic Profiling
Part 2 of "Are you getting the full picture? A series on the power of comprehensive intelligent diagnostics."
Speakers
Internal
Ezra Cohen, MD
Chief Medical Officer of Oncology, Tempus
External
Frank Weinberg, MD
Assistant Professor, University of Illinois College of Medicine Lead, Thoracic Oncology Program UI Health
Ezra Cohen, MD
Chief Medical Officer of Oncology, Tempus
External
Frank Weinberg, MD
Assistant Professor, University of Illinois College of Medicine Lead, Thoracic Oncology Program UI Health
Watch the recording for part 1, One Blood Sample, Many Options: The Benefits of Tumor + Normal Match ↗
-
06/25/2024Revolutionizing Cardiac Care: AI-driven detection and treatment of critical heart valve disease at Boulder Community Health
Discover how Tempus Next's AI-powered care pathway platform transformed patient outcomes by helping ensure timely, guideline-directed treatment for critical heart valve disease at Boulder Community Health
Read more -
04/15/2024Identifying patients with Valvular Heart Disease: A partnership between St.Francis and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution at St. Francis enabled guideline directed care for patients with structural heart disease.
Read more -
04/15/2024Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more